Health and Wellbeing of Pregnant and Post-Partum Women During the COVID-19 Pandemic

Pregistry6,894 enrolled

Overview

The purpose of this study is to assess the health and wellbeing of pregnant and recently pregnant women during the COVID-19 pandemic using an online survey.

Millions of women will give birth during the pandemic of Coronavirus Disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The consequences of COVID-19 for pregnant women and their offspring are unknown. This lack of information leads to anxiety among pregnant women, women who are considering getting pregnant, and their families. It is therefore important to assess the wellbeing and mental health of women during the COVID-19 pandemic. The international nature of the online survey will allow the evaluation of how living during the COVID-19 pandemic affects pregnant and recently pregnant women at a global level, including the evaluation of potential cultural and geographic differences.

Study Type

OBSERVATIONAL

Enrollment

6,894

Conditions

COVID-19 Pregnancy Complications Mental Health Wellness 1 Anxiety Depression Ptsd Coronavirus

Interventions

This is an online survey with no intervention.OTHER

As this is an online survey about health and wellbeing, there is no intervention.

Eligibility

Sex: FEMALEMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Pregnant women or women who have been pregnant within the last 6 months * Able to give electronic informed consent Exclusion Criteria: * \<18 years of age

Locations (1)

Pregistry

Los Angeles, California, United States

Outcomes

Primary Outcomes

Number of Participants With Symptoms of Post-traumatic Stress Disorder

Post-traumatic Stress Disorder (PTSD) Symptoms will be assessed by the Impact of Events Scale-6. This scale includes a total of six items: two items from each of the three subscales of the measure, namely intrusion, hyperarousal and avoidance. Participants will be asked to report their PTSD symptoms in the past 7 days on a Likert Scale ranging from 0 (not at all) to 4 (extremely).

Time frame: Anytime during pregnancy or within 6 months after given birth.

Number of Participants With Symptoms of Anxiety and Depression

Symptoms of anxiety and depression will be measured by the Patient Health Questionnaire-4 (PHQ-4) which combines two ultrabrief screeners: the PHQ-2 and the Generalised Anxiety Disorder Scale. Participants will be asked to report their symptoms of depression and anxiety in the past 2 weeks on a Likert Scale from 0 (not at all) to 3 (nearly every day) for a maximum score of 12.

Time frame: Anytime during pregnancy or within 6 months after given birth.

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.